Results 201 to 210 of about 132,601 (358)

Experimental oligocythaemia and splenomegaly

open access: green, 1939
John Mellanby, S. F. Suffolk
openalex   +1 more source

Behcet's disease and splenomegaly. [PDF]

open access: yesBMJ, 1978
Kiernan, T J   +3 more
openaire   +3 more sources

Phenotypic patterns of metabolic dysfunction‐associated steatotic liver disease in type 2 diabetes: The impact of insulin

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Abstract Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) often leads to hepatic insulin resistance (IR), yet its link to liver‐specific insulin‐mediated glucose uptake (IGLU) in type 2 diabetes (T2D) remains unclear. We aimed to explore this MASLD‐T2D relationship, addressing organ‐specific IR for personalized management and
Queralt Martín‐Saladich   +12 more
wiley   +1 more source

Splenomegaly with Leucopenia [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1946
openaire   +3 more sources

Massive splenomegaly [PDF]

open access: yesBMJ Case Reports, 2013
Hugo L, Paz-Y-Mar   +2 more
openaire   +2 more sources

Treatment‐Free Remission in Chronic Myeloid Leukemia: Revisiting the “W” Questions

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Chronic myeloid leukemia (CML) has undergone a transformation from a fatal disease to a chronic, manageable condition with the advent of tyrosine kinase inhibitors (TKIs), particularly imatinib. This shift has significantly improved survival rates, and for some patients, achieving deep molecular response (DMR) has made treatment‐free remission
Antonella Bruzzese   +9 more
wiley   +1 more source

Splenomegaly

open access: yesInternational Journal of Clinical Practice, 1955
openaire   +2 more sources

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis

open access: yesLeukemia, 2016
M. Jawhar   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy